Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mutations01:39

Mutations

Overview
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of Native COMPASS Complex in Urothelial Carcinoma Cells by Size Exclusion Chromatography.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

Proteomic and transcriptomic profiles of human urothelial cancer cells with histone deacetylase 5 overexpression.

Scientific data·2022
Same author

Retraction Note: Aging-associated distinctive DNA methylation changes of LINE-1 retrotransposons in pure cell-free DNA from human blood.

Scientific reports·2022
Same author

Epigenetics in the Diagnosis and Therapy of Malignant Melanoma.

International journal of molecular sciences·2022
Same author

Alterations of Chromatin Regulators in the Pathogenesis of Urinary Bladder Urothelial Carcinoma.

Cancers·2021
Same author

The Dual Histone Deacetylase-Proteasome Inhibitor RTS-V5 Acts Synergistically With Ritonavir to Induce Endoplasmic Reticulum Stress in Bladder Cancer Cells.

Anticancer research·2021

Related Experiment Video

Updated: Jul 7, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Chromosomal instability in bladder cancer.

Andrea R Florl1, Wolfgang A Schulz

  • 1Department of Urology, Heinrich-Heine-University Duesseldorf, Urologische Klinik, Heinrich-Heine-Universität, Moorenstr. 5, 40225 Dusseldorf, Germany. florl@uni-duesseldorf.de

Archives of Toxicology
|February 7, 2008
PubMed
Summary
This summary is machine-generated.

Chromosomal instability (CIN) in urothelial carcinoma arises from checkpoint dysfunction, leading to aneuploidy. Further research is needed to understand telomere roles and DNA repair mechanisms in cancer development.

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Related Experiment Videos

Last Updated: Jul 7, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Area of Science:

  • Oncology
  • Genetics
  • Cell Biology

Background:

  • Chromosomal instability (CIN) differentiates invasive urothelial carcinomas from papillary subtypes.
  • Checkpoint dysfunction is increasingly recognized as a driver of aneuploidy in urothelial carcinogenesis.
  • CIN may also contribute to DNA repair defects, exacerbating genomic instability.

Purpose of the Study:

  • To explore the mechanisms underlying chromosomal instability in urothelial carcinogenesis.
  • To investigate the role of checkpoint dysfunction and DNA repair defects in aneuploidy.
  • To elucidate the specific pathways, including telomere dynamics and breakage-fusion-bridge cycles, contributing to CIN.

Main Methods:

  • The study reviews existing literature and experimental findings on chromosomal instability in urothelial carcinomas.
  • It discusses the implications of cell cycle regulation, p53 function, and checkpoint signaling.
  • Focus is placed on mechanisms like telomere erosion, telomerase activation, and DNA double-strand break repair.

Main Results:

  • Defects in cell cycle regulation and checkpoint signaling, potentially initiated by carcinogens, can lead to CIN.
  • Breakage-fusion-bridge (BFB) cycles, initiated by telomere defects, are a key mechanism for aneuploidy.
  • A distinct mechanism appears responsible for large interstitial deletions, such as those at 9p21.

Conclusions:

  • Checkpoint dysfunction is a critical factor in urothelial carcinogenesis, driving aneuploidy and CIN.
  • Understanding the interplay between telomere maintenance, DNA repair, and CIN is crucial for developing targeted therapies.
  • Further experimental investigation is required to fully resolve the complex mechanisms driving CIN and large deletions in urothelial cancers.